• Markets
  • icon
  • Companies
RNO · ASX

Rhinomed Limited (ASX:RNO)

AU$0.04

 0.0 (0.0%)
ASX:Live
21/02/2024 12:00:00 AM
HALO Ords GROWTH AUS All-Companies
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

RNO Overview

RNO Health Scores

Short Term

Mean Revision

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Strong

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About RNO

Telephone

Address

Description

Rhinomed Ltd. is medical technology company, which engages in the identification, acquisition, and commercialization of stage therapeutic delivery technologies. It operates through Turbine, Mute and Pronto technology. The Turbine technology, a nasal dilator designed to assist breathe during aerobic exercise. The Mute technology, a nasal technology that is designed to improve sleep by breathing more and snoring less. The Pronto technology is a Vapor Inhaler, which opens the nose to improve airflow and delivers the soothing vapors from essential oils. The company was founded on February 9, 2004 and is headquartered in Cremorne, Australia.

RNO Price Chart

Key Stats

Market Cap

AU$11.34M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.02 - 0.1

Trade Value (12mth)

AU$1,412.00

1 week

0%

1 month

53.85%

YTD

33.33%

1 year

-55.56%

All time high

6.15826

Key Fundamentals

EPS 3 yr Growth

-13.200%

EBITDA Margin

-121.70%

Operating Cashflow

-$7m

Free Cash Flow Return

0.00%

ROIC

0.00%

Interest Coverage

-29.10

Quick Ratio

0.20

Other Data

Shares on Issue (Fully Dilluted)

0m

HALO Sector

Next Company Report Date

28-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

RNO Announcements

Latest Announcements

Date Announcements

16 February 24

Removal from Official List

×

Removal from Official List

14 February 24

Suspension from Official Quotation

×

Suspension from Official Quotation

13 February 24

Change in substantial holding WG

×

Change in substantial holding WG

07 February 24

Notification of cessation of securities - RNO

×

Notification of cessation of securities - RNO

02 February 24

Results of Minimum Holding Buy-Back

×

Results of Minimum Holding Buy-Back

31 January 24

Monthly Activities/Appendix 4C Cash Flow Report

×

Monthly Activities/Appendix 4C Cash Flow Report

30 January 24

App 3Y MJ

×

App 3Y MJ

29 January 24

Results of SPP

×

Results of SPP

29 January 24

Proposed issue of securities - RNO

×

Proposed issue of securities - RNO

29 January 24

Application for quotation of securities - RNO

×

Application for quotation of securities - RNO

16 January 24

Results of EGM

×

Results of EGM

18 December 23

Cleansing Notice - SPP

×

Cleansing Notice - SPP

18 December 23

Share Purchase Plan

×

Share Purchase Plan

11 December 23

Delisting Announcement

×

Delisting Announcement

11 December 23

Minimum holding buy-back

×

Minimum holding buy-back

11 December 23

Share Purchase Plan Offer

×

Share Purchase Plan Offer

11 December 23

Notice of Extraordinary General Meeting/Proxy Form

×

Notice of Extraordinary General Meeting/Proxy Form

11 December 23

Proposed issue of securities - RNO

×

Proposed issue of securities - RNO

11 December 23

Rhinomed investor webinar

×

Rhinomed investor webinar

07 December 23

Trading Halt

×

Trading Halt

17 November 23

Final Director's Interest Notice BS

×

Final Director's Interest Notice BS

17 November 23

Chair's Address to Shareholders

×

Chair's Address to Shareholders

17 November 23

CEO Presentation to AGM

×

CEO Presentation to AGM

17 November 23

Results of Meeting AGM 2023

×

Results of Meeting AGM 2023

27 October 23

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

27 October 23

Rhinomed Ltd Appendix 4G

×

Rhinomed Ltd Appendix 4G

RNO Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.03 -0.02 -0.04 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.03 -0.02 -0.04 Lock Lock Lock
     Growth % Lock Lock Lock Lock 23.2 40.2 -89.1 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.02 -0.02 -0.03 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.02 -0.03 -0.03 Lock Lock Lock
     Growth % Lock Lock Lock Lock -11.7 18.6 -46.0 Lock Lock Lock
     Yield % Lock Lock Lock Lock -13.7 -22.0 -36.4 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.02 0.02 -0.02 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.01 0.01 -0.02 Lock Lock Lock
     Growth % Lock Lock Lock Lock -69.4 11.8 -302.4 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 256 262 286 Lock Lock Lock
Basic m Lock Lock Lock Lock 256 262 286 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 4 9 7 Lock Lock Lock
     Growth % Lock Lock Lock Lock 9.2 133.8 -17.9 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 6 8 8 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock -3 2 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock -10.5 152.5 -111.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock -79.2 17.8 -2.5 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 179 82 103 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -8 -5 -9 Lock Lock Lock
     Growth % Lock Lock Lock Lock -23.5 34.9 -69.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock -211.7 -59.0 -121.7 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 1 1 1 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -9 -6 -10 Lock Lock Lock
     Growth % Lock Lock Lock Lock -21.5 31.3 -64.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock -226.9 -66.7 -133.7 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -9 -6 -11 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 -1 -1 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -9 -5 -11 Lock Lock Lock
     Growth % Lock Lock Lock Lock -18.9 38.9 -106.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock -221.8 -58.0 -146.0 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -5 -6 -7 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 1 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 -1 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 0 6 5 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -5 -7 -7 Lock Lock Lock
     Growth % Lock Lock Lock Lock 6.4 -23.0 -9.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock -1.4 -0.7 -1.0 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 2 2 0 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 7 8 3 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -2 -2 6 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 2 3 9 Lock Lock Lock
Equity $m Lock Lock Lock Lock 5 5 -6 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 5 5 -6 Lock Lock Lock
     Growth % Lock Lock Lock Lock -55.0 2.3 -222.4 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -131.9 -62.1 -354.7 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -181.3 -104.9 170.3 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -106.0 -114.4 -404.3 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -105.2 -102.3 0.0 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -64.9 -111.3 0.0 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock -201.9 -121.3 -29.1 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 0.2 0.3 -0.6 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -39.2 -32.7 -90.3 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 2.7 1.7 0.3 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 2.6 1.3 0.2 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 62.4 35.9 7.5 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -385.7 -179.8 -76.5 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 3.7 5.6 4.2 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 20.0 10.7 8.2 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 1.6 3.9 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 18.4 19.8 22.9 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.6 1.1 2.4 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.6 1.1 2.4 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -232.7 -63.5 -153.2 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -138.4 -68.0 -372.3 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -131.9 -62.1 -354.7 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.4 1.7 -0.5 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -181.3 -104.9 170.3 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -181.3 -104.9 170.3 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 18.2 34.1 44.6 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 97.4 64.7 87.7 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 115.6 98.8 132.3 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 28.5 53.7 91.1 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 87.1 45.1 41.1 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

RNO Shortsell

Frequently Asked Questions

The current share price of Rhinomed Limited (RNO:ASX) is AU$0.04.
The 52-week high share price for Rhinomed Limited (RNO:ASX) is AU$0.10.
The 52-week low share price for Rhinomed Limited (RNO:ASX)? is AU$0.02.
Rhinomed Limited (RNO:ASX) does not pay a dividend.
Rhinomed Limited (RNO:ASX) does not pay a dividend.
Rhinomed Limited (RNO:ASX) has a franking level of 0%.
Rhinomed Limited (RNO:ASX) is classified in the Healthcare.
The current P/E ratio for Rhinomed Limited (RNO:ASX) is .